Janice Canvin
Horsham St Faith, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic Asthma.
Journal: American journal of respiratory and critical care medicine
Published: October 23, 2018
Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy.
Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy.
Journal: ERJ open research
Published: January 06, 2017
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Journal: Theranostics
Published: November 11, 2016
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
Journal: Allergy
Published: February 26, 2016
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study.
Journal: The Journal of investigative dermatology
Published: December 16, 2014
Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE.
Journal: Regulatory toxicology and pharmacology : RTP
Published: September 25, 2014
Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting.
Journal: Biologics in therapy
Published: August 25, 2014
Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'.
Journal: The British journal of dermatology
Published: July 29, 2014
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.
Journal: The Journal of investigative dermatology
Published: March 06, 2014
Omalizumab in asthma: an update on recent developments.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 29, 2013
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
Journal: The Journal of allergy and clinical immunology
Published: April 16, 2013
Last Updated: 09/26/2026